Replimune Group REPL Business Segments — Operating Expenses

Similar metrics at other companies

VRDNReportable Segment — Operating Expenses

$116.19M+23.8%

ALLOReportable Segment — Operating Expenses

$46.09M-29.3%

BCAXReportable Segment — Total Operating Expenses

$60.24M+44.2%

PCVXReportable Segment — Operating Expenses

$345.85M+91.3%

PRMEReportable Segment — Operating Expenses

$51.51M-4.3%

HYLNReportable Segment — Operating Expenses

$13.4M-32.3%

Questions, answered.

What is Replimune Group's business segments — operating expenses?

Replimune Group (REPL) reported business segments — operating expenses of $71.87M in Q4 2025.

How has Replimune Group's business segments — operating expenses changed year-over-year?

Replimune Group's business segments — operating expenses increased by 8.9% year-over-year, from $66.02M to $71.87M.

What does business segments — operating expenses mean?

The total aggregate cost of running the business, encompassing both research and development activities and general administrative functions. This figure serves as a primary indicator of the company's cash burn rate and overall operational scale during the clinical development phase.